(PDF) P1.15-08 Implementation and Feasibility of the

P1.15-08 Implementation and Feasibility of the Assessment of EGFR Mutation in NSCLC Using Liquid Biopsy at an Argentinean University Hospital

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.940

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

E. Rojas Bilbao

Publisher

Elsevier BV

Related search

P1.15-30 Survival of Patients With Advanced NSCLC Treated With First-Generation EGFR-TKIs at a Cancer Hospital in Thailand, 2011-2016

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.13-28 Comparison of ddPCR and NGS in Liquid Biopsy to Pathology Results in EGFR-Mutated NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.01-80 Retrospective Analysis of the Impact of EGFR T790M Mutation Detection by Re-Biopsy in Patients With NSCLC Harboring EGFR Mutations.

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.13-14 the Clinical Usefulness of Liquid Biopsy for Detection and Dynamic Monitoring of EGFR T790M in NSCLC Patients on EGFR-TKI Therapy

Journal of Thoracic Oncology

Respiratory Medicine

English

P061 Real Clinical Practice of Using Immunotherapy in NSCLC Patients With EGFR Mutation

Journal of Thoracic Oncology

Respiratory Medicine

English

Liquid Biopsy Holds Its Own in NSCLC

Cancer Discovery

English

P1.15-05 the Frequency and Spectrum of EGFR Exon 20 Insertions in NSCLC: A Global Literature Review

Journal of Thoracic Oncology

Respiratory Medicine

English

Comparison of EGFR-TKI and Chemotherapy in the First-Line Treatment of Advanced EGFR Mutation-Positive NSCLC

Cancer Research

English

P2.03-016 Clinical Utility of Liquid Biopsy for Detecting EGFR T790M Mutation Is Very Limited

Journal of Thoracic Oncology

Respiratory Medicine

English